Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2Phase 3 1Phase 1 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Thyroid Neoplasms 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Neoplasm Metastasis 1Carcinoma, Medullary 1

Interventions

lenvatinib 3cabozantinib 2Thyrotropin Alfa 2vandetanib 1trametinib 1sintilimab 1selpercatinib 1pralsetinib 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1larotrectinib 1dabrafenib 1anlotinib 1acetaminophen, codeine drug combination 1Tramadol 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sunitinib 1Sodium Chloride 1Ondansetron 1Negative-Pressure Wound Therapy 1Indocyanine Green 1Fentanyl 1Conversion to Open Surgery 1Capsules 1Aprepitant 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Thyroid Neoplasms × cabozantinib × Clear all
NCT01896479 2025-09-02

EXAMINER

Exelixis

Phase 4 Active not recruiting
247 enrolled 14 charts
Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

NCT07010393 2025-06-08

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Fujian Medical University

Phase 4 Not yet recruiting
335 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡